Veradermics MANE
NYSE MANE
$152.55 +4.11 (+2.77%)
As of: Nov 11, 2026 · 12:40 PM EST

Veradermics (MANE) Other Non Operating Income (2025 - 2026)

Updated

Veradermics' Other Non Operating Income came in at $1.21 million for Q2 2026, up 273.2% from $325,000 a year earlier and up 714.1% from the prior quarter.

Analysis

Veradermics (MANE) Other Non Operating Income (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Veradermics reported Other Non Operating Income of $1.72 million; for FY2025, it came in at $790,000, up 100.5% from FY2024.

  • Going back by year, Other Non Operating Income was $394,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Veradermics 822.06 Mn -1.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.68 Mn
Jun 30, 2026 1.21 Mn
Mar 31, 2026 149,000.00
Dec 31, 2025 258,000.00
Sep 30, 2025 174,000.00
Jun 30, 2025 325,000.00
Mar 31, 2025 33,000.00
API Access

Veradermics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=MANE&period=max&api_key=YOUR_API_KEY